8-K
filed April 26, 2023, 7:59 PM ET
ticker MXL
CIK 0001288469
earnings
confidence high
sentiment negative
materiality 0.75
MaxLinear Q1 revenue $248.4M, down 15% QoQ; Q2 guidance $175M-$205M, well below Q1
MAXLINEAR, INC
2023-Q1 EPS reported
$0.12
revenue$248,442,000
- GAAP EPS $0.12 vs $0.42 YoY; non-GAAP EPS $0.74 vs $1.00 YoY; revenue down 6% YoY.
- Infrastructure revenue $46.3M, up 46% QoQ and 40% YoY, driven by 5G wireless backhaul.
- Q2 revenue guidance $175M-$205M implies at least 17% sequential decline; GAAP gross margin 54.5%-57.5%.
- Operating cash flow $42.2M, down 39% QoQ and 69% YoY.
- Pending acquisition of Silicon Motion continues antitrust approval process.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
MAXLINEAR, INC reported first quarter ended March 31, 2023 results: revenue $248.4 million, EPS $0.12.
- Period
- first quarter ended March 31, 2023
- Revenue
- $248.4 million
- EPS
- $0.12
- Result
- reported results
Exact text from the filing
forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE MaxLinear, Inc. Announces First Quarter 2023 Financial Results • Net revenue of $248.4 million in Q1, GAAP gross margin of 56.5% and non-GAAP gross margin of 60.3% • Infrastructure revenue was $46.3 million in Q1, up 46% sequentially and up 40% YoY Carlsbad, Calif. – April
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
MAXLINEAR, INC reported second quarter of 2023 results: revenue approximately $175 million to $205 million. Guidance reaffirmed.
- Period
- second quarter of 2023
- Revenue
- approximately $175 million to $205 million
- Guidance
- reaffirmed
- Result
- guidance update
Exact text from the filing
The company expects net revenue in the second quarter of 2023 to be approximately $175 million to $205 million.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.